Fig. 1.

Study protocol. After improvement in glycemic control by multiple insulin injection therapy (MIIT), treatment was switched to liraglutide. Blood samples were collected during meal tests before and after the change in therapy. In addition, patients who gave consent had their 24-h glucose levels measured by continuous glucose monitoring (CGM).